Lab test picks best drugs for tough brain cancers
NCT ID NCT06804655
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 27 times
Summary
This study tests a new approach called pharmacoscopy for people with brain tumors that have not responded to standard treatments. The method uses a lab test on a patient's own tumor cells to find which drugs might work best for them. The goal is to see if this personalized way of choosing treatment is practical and can help control the disease. About 40 adults with various types of brain tumors will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cantonal Hospital St Gallen
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Basel
Basel, Basel-Landschaft, 4021, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.